Araştırma Makalesi
BibTex RIS Kaynak Göster

Intralesional interferon alfa-2a therapy in adult hemangiomas

Yıl 1995, Cilt: 8 Sayı: 2, 67 - 72, 01.03.1995

Öz

Hemangiomas, mostly appearing in infancy, generally involute completely and with their complications, rarely demand medical or surgical intervention. On the other hand, hemangiomas of adult life are persistant and usually no problems other than cosmetic ones accompany the lesions. So, appropriate methods, with no complications and side effects, must be preferred in the treatment. Most of the prior methods are usually inadequate in the management of the process.

Regression effect of systemic interferon treatment on infantile hemangiomas was perceived before. Similarly, we injected interferon alfa-2a into the adult hemangiomas three times a week, for three weeks and observed regression of the lesions by morphologic, histopathologic and ultrastructural evaluation.

Kaynakça

  • Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Pediatr Scand 1955;44:370-379.
Yıl 1995, Cilt: 8 Sayı: 2, 67 - 72, 01.03.1995

Öz

Kaynakça

  • Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Pediatr Scand 1955;44:370-379.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Konular Klinik Tıp Bilimleri
Bölüm Derleme
Yazarlar

N. Durak Bu kişi benim

E. Kışlaoğlu Bu kişi benim

F. Yüksel Bu kişi benim

İ. Okar Bu kişi benim

T. Şan Bu kişi benim

Yayımlanma Tarihi 1 Mart 1995
Yayımlandığı Sayı Yıl 1995 Cilt: 8 Sayı: 2

Kaynak Göster

APA Durak, N., Kışlaoğlu, E., Yüksel, F., Okar, İ., vd. (1995). Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Medical Journal, 8(2), 67-72.
AMA Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T. Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Med J. Mart 1995;8(2):67-72.
Chicago Durak, N., E. Kışlaoğlu, F. Yüksel, İ. Okar, ve T. Şan. “Intralesional Interferon Alfa-2a Therapy in Adult Hemangiomas”. Marmara Medical Journal 8, sy. 2 (Mart 1995): 67-72.
EndNote Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T (01 Mart 1995) Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Medical Journal 8 2 67–72.
IEEE N. Durak, E. Kışlaoğlu, F. Yüksel, İ. Okar, ve T. Şan, “Intralesional interferon alfa-2a therapy in adult hemangiomas”, Marmara Med J, c. 8, sy. 2, ss. 67–72, 1995.
ISNAD Durak, N. vd. “Intralesional Interferon Alfa-2a Therapy in Adult Hemangiomas”. Marmara Medical Journal 8/2 (Mart 1995), 67-72.
JAMA Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T. Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Med J. 1995;8:67–72.
MLA Durak, N. vd. “Intralesional Interferon Alfa-2a Therapy in Adult Hemangiomas”. Marmara Medical Journal, c. 8, sy. 2, 1995, ss. 67-72.
Vancouver Durak N, Kışlaoğlu E, Yüksel F, Okar İ, Şan T. Intralesional interferon alfa-2a therapy in adult hemangiomas. Marmara Med J. 1995;8(2):67-72.